CHPA Rebranding Reflects Growing Device Interests In Evolving Self-Care Market
Executive Summary
The Consumer Healthcare Products Association’s rebranding initiative – its first in 20 years – aligns the group with today’s self-care marketplace where consumer medical devices play an increasingly prominent role. It also follows “landmark legislative achievements in 2020 that will further empower consumers to practice responsible self-care,” CHPA says.
You may also be interested in...
US OTC Market In 2020: COVID-19 Impact Obvious In Medical Device As Well As Drug Sales Growth
Most notably among OTC drugs, hand sanitizer sales were up more than 600% to $1.46bn, while sales of consumer medical devices grew 15.6% to $14.8bn in 2020, according to CHPA report.
HBW Executive Decisions: HPCUS Service Award For Land; Supplement VP New At CHPA; ACI Adds Microbiology Director; ABC Awards; More
Mark Land receives HPCUS “Service to Homeopathy Award”; CHPA appoints John Troup to new post of dietary supplements executive; P&G’s Paul Gama elected CHPA board chair; FDA fellow, microbiology expert Queen joins ACI; more executive hires in consumer health and beauty sectors.
US Pandemic Relief Package Delivers OTC Industry Regulatory Wishes, Supplement Business Hopes
It’s unlikely any industry stakeholder or FDA official expected a bill providing emergency economic relief to consumers, industries and health care services and facilities in response to a pandemic, including extensive support opportunities for small businesses, would be the vehicle that delivers on both of the industry’s congressional wishes. The supplement industry also looks for help in CARES Act.